Gender Differences in HIV Care among Criminal Justice-Involved Persons: Baseline Data from the CARE+ Corrections Study

Curt Beckwith, Breana Uhrig Castonguay, Claudia Trezza, Lauri Bazerman, Rudy Patrick, Alice Cates, Halli Olsen, Ann Kurth, Tao Liu, James Peterson, Irene Kuo, Curt Beckwith, Breana Uhrig Castonguay, Claudia Trezza, Lauri Bazerman, Rudy Patrick, Alice Cates, Halli Olsen, Ann Kurth, Tao Liu, James Peterson, Irene Kuo

Abstract

Background: HIV-infected individuals recently released from incarceration have suboptimal linkage and engagement in community HIV care. We conducted a study to evaluate an information and communication technology intervention to increase linkage to community care among HIV-infected persons recently involved in the criminal justice (CJ) system. Baseline characteristics including risk behaviors and HIV care indicators are reported and stratified by gender.

Methods: We recruited HIV-infected individuals in the District of Columbia jail and persons with a recent history of incarceration through community and street outreach. Participants completed a baseline computer-assisted personal interview regarding HIV care and antiretroviral treatment (ART) adherence, substance use, and sexual behaviors. CD4 and HIV plasma viral load testing were performed at baseline or obtained through medical records. Data were analyzed for the sample overall and stratified by gender.

Results: Of 110 individuals, 70% were community-enrolled, mean age was 40 (SD = 10.5), 85% were Black, and 58% were male, 24% female, and 18% transgender women. Nearly half (47%) had condomless sex in the three months prior to incarceration. Although drug dependence and hazardous alcohol use were highly prevalent overall, transgender women were more likely to have participated in drug treatment than men and women (90%, 61%, and 50% respectively; p = 0.01). Prior to their most recent incarceration, 80% had an HIV provider and 91% had ever taken ART. Among those, only 51% reported ≥90% ART adherence. Fewer women (67%) had received HIV medications during their last incarceration compared to men (96%) and transgender women (95%; p = 0.001). Although neither was statistically significant, transgender women and men had higher proportions of baseline HIV viral suppression compared to women (80%, 69%, and 48.0% respectively, p>0.05); a higher proportion of women had a CD4 count ≤200 compared to men and transgender women (17%, 8% and 5% respectively; p>0.05).

Conclusions: In this study, HIV-infected persons with recent incarceration in Washington, DC reported important risk factors and co-morbidities, yet the majority had access to HIV care and ART prior to, during, and after incarceration. Self-reported ART adherence was sub-optimal, and while there were not statistically significant differences, CJ-involved women appeared to be at greatest risk of poor HIV outcomes.

Trial registration: Registered on ClinicalTrials.gov on 10/16/2012. Reference number: NCT01721226.

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Fig 1. CONSORT Diagram.
Fig 1. CONSORT Diagram.

References

    1. Binswanger IA, Redmond N, Steiner JF, Hicks LS. Health disparities and the criminal justice system: an agenda for further research and action. J Urban Health, 2012. 89(1): p. 98–107. 10.1007/s11524-011-9614-1
    1. Shubert G. Mass Incarceration, Housing instability and HIV/AIDS: Research Findings and Policy Recommendations: a report on the effects of incarceration and HIV/AIDS on marginalized communities. 2013, National Minority AIDS Council and Housing Works: National Minority AIDS Council and Housing Works. p. 38.
    1. Iroh PA, Mayo H, Nijhawan AE. The HIV Care Cascade Before, During, and After Incarceration: A Systematic Review and Data Synthesis. Am J Public Health, 2015. 105(7): p. e5–16. 10.2105/AJPH.2015.302635
    1. Baillargeon J, Giordano TP, Rich JD, Wu ZH, Wells K, Pollock BH, et al. Accessing antiretroviral therapy following release from prison. JAMA, 2009. 301(8): p. 848–57. 10.1001/jama.2009.202
    1. Stephenson BL, Wohl DA, Golin CE, Tien HC, Stewart P, Kaplan AH. Effect of release from prison and re-incarceration on the viral loads of HIV-infected individuals. Public Health Rep, 2005. 120(1): p. 84–8.
    1. Clements-Nolle K, Marx R, Pendo M, Loughran E, Estes M, Katz M. Highly active antiretroviral therapy use and HIV transmission risk behaviors among individuals who are HIV infected and were recently released from jail. Am J Public Health, 2008. 98(4): p. 661–6. 10.2105/AJPH.2007.112656
    1. Dennis AC, Barrington C, Hino S, Gould M, Wohl D, Golin CE. "You're in a world of chaos": experiences accessing HIV care and adhering to medications after incarceration. J Assoc Nurses AIDS Care, 2015. 26(5): p. 542–55. 10.1016/j.jana.2015.06.001
    1. Spaulding AC, Seals RM, Page MJ, Brzozowski AK, Rhodes W, Hammett TM. HIV/AIDS among inmates of and releasees from US correctional facilities, 2006: declining share of epidemic but persistent public health opportunity. PLoS One, 2009. 4(11): p. e7558 10.1371/journal.pone.0007558
    1. Carson E.A., Prisoners in 2014, U.S.D.o. Justice, Editor. 2014, Bureau of Justice Statistics: Washington, D.C.
    1. Kaeble D, Maruschak LM, Bonczar TP. Probation and Parole in the United States, 2014; 2015, Bureau of Justice Statistics: Washington, D.C.
    1. Fazel S., Bains P., and Doll H., Substance abuse and dependence in prisoners: a systematic review. Addiction, 2006. 101(2): p. 181–91. 10.1111/j.1360-0443.2006.01316.x
    1. Proctor SL. Substance use disorder prevalence among female state prison inmates. Am J Drug Alcohol Abuse, 2012. 38(4): p. 278–85. 10.3109/00952990.2012.668596
    1. Maruschak LM, Beavers R. HIV in prisons, 2007–2008 U.S.D.o. Justice, Editor. 2010, Bureau of Justice Statistics: Washington, D.C.
    1. Beckwith CG, Zaller ND, Fu JJ, Montague BT, Rich JD. Opportunities to diagnose, treat, and prevent HIV in the criminal justice system. J Acquir Immune Defic Syndr, 2010. 55 Suppl 1: p. S49–55.
    1. Staton-Tindall M, Webster JM, Oser CB, Havens JR, Leukefeld CG. Drug use, hepatitis C, and service availability: perspectives of incarcerated rural women. Soc Work Public Health, 2015. 30(4): p. 385–96. 10.1080/19371918.2015.1021024
    1. Binswanger IA, Merrill JO, Krueger PM, White MC, Booth RE, Elmore JG. Gender differences in chronic medical, psychiatric, and substance-dependence disorders among jail inmates. Am J Public Health, 2010. 100(3): p. 476–82. 10.2105/AJPH.2008.149591
    1. Meyer JP, Zelenev A, Wickersham JA, Williams CT, Teixeira PA, Altice FL. Gender disparities in HIV treatment outcomes following release from jail: results from a multicenter study. Am J Public Health, 2014. 104(3): p. 434–41. 10.2105/AJPH.2013.301553
    1. Kim S, Johnson TP, Goswami S, Puisis M. Risk factors for homelessness and sex trade among incarcerated women: A Structural equation model. J Int Womens Stud, 2011. 12(1): p. 128–148.
    1. Herbst JH, Jacobs ED, Finlayson TJ, McKleroy VS, Neumann MS, Crepaz N, et al. Estimating HIV prevalence and risk behaviors of transgender persons in the United States: a systematic review. AIDS Behav, 2008. 12(1): p. 1–17. 10.1007/s10461-007-9299-3
    1. Baral SD, Poteat T, Stromdahl S, Wirtz AL, Guadamuz TW, Beyrer C. Worldwide burden of HIV in transgender women: a systematic review and meta-analysis. Lancet Infect Dis, 2013. 13(3): p. 214–22. 10.1016/S1473-3099(12)70315-8
    1. Sexton L, Jenness V, Sumner JM. Where the Margins Meet: A Demographic Assessment of Transgender Inmates in Men's Prisons. Justice Quarterly, 2010. 27(6): p. 835–866.
    1. Fletcher JB, Kisler KA, Reback CJ. Housing Status and HIV Risk Behaviors Among Transgender Women in Los Angeles. Archives of Sexual Behavior, 2014. 43(8): p. 1651–1661. 10.1007/s10508-014-0368-1
    1. Lombardi EL,Wilchins RA, Priesing D, Malouf D. Gender violence: Transgender experiences with violence and discrimination. Journal of Homosexuality, 2001. 42(1): p. 89–101.
    1. Hartzell E, Frazer MS, Wertz K, Davis M, The State of Transgender California: Results from the 2008 California Transgender Economic Health Survey 2009, Transgender Law Center: San Francisco, CA.
    1. Hwahng SJ, Nuttbrock L. Sex Workers, Fem Queens, and Cross-Dressers: Differential Marginalizations and HIV Vulnerabilities Among Three Ethnocultural Male-to-Female Transgender Communities in New York City. Sex Res Social Policy, 2007. 4(4): p. 36–59. 10.1525/srsp.2007.4.4.36
    1. Chandler RK, Kahana SY, Fletcher B, Jones D, Finger MS, Aklin WM, et al. Data Collection and Harmonization in HIV Research: The Seek, Test, Treat, and Retain Initiative at the National Institute on Drug Abuse. Am J Public Health, 2015. 105(12): p. 2416–22. 10.2105/AJPH.2015.302788
    1. Check Hayden E. 'Seek, test and treat' slows HIV. Nature, 2010. 463(7284): p. 1006 10.1038/4631006a
    1. Taege A. Seek and treat: HIV update 2011. Cleve Clin J Med, 2011. 78(2): p. 95–100. 10.3949/ccjm.78gr.10003
    1. Granich RM, Gilks CF, Dye C, De Cock KM, Williams BG. Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model. Lancet, 2009. 373(9657): p. 48–57. 10.1016/S0140-6736(08)61697-9
    1. Strategic Information Division, S.T.C.D., Hepatitis Coordinator, The George Washington University Milken Institute School of Public Health, District of Columbia The Annual Epidemiology & Surveillance Report 2014, D.D.o. Health, Editor. 2014, HIV/AIDS, Hepatitis, STD and TB Administration (HAHSTA): Washington, D.C.
    1. Kurth A, Kuo I, Peterson J, Azikiwe N, Bazerman L, Cates A, et al. Information and Communication Technology to Link Criminal Justice Reentrants to HIV Care in the Community. AIDS Res Treat, 2013. 2013: p. 547381.
    1. Skeels MM, Kurth A, Clausen M, Severynen A, Garcia-Smith H. CARE+ user study: usability and attitudes towards a tablet pc computer counseling tool for HIV+ men and women. AMIA Annu Symp Proc, 2006: p. 729–33.
    1. Spielberg F, Kurth AE, Severynen A, Hsieh YH, Moring-Parris D, Mackenzie S, et al. Computer-facilitated rapid HIV testing in emergency care settings: provider and patient usability and acceptability. AIDS Educ Prev, 2011. 23(3): p. 206–21. 10.1521/aeap.2011.23.3.206
    1. Peterson J, Cota M, Gray H, Bazerman L, Kuo I, Kurth A, et al. Technology use in linking criminal justice reentrants to HIV care in the community: a qualitative formative research study. J Health Commun, 2015. 20(3): p. 245–51. 10.1080/10810730.2014.927036
    1. Daeppen JB, Yersin B, Landry U, Pecoud A, Decrey H. Reliability and validity of the Alcohol Use Disorders Identification Test (AUDIT) imbedded within a general health risk screening questionnaire: results of a survey in 332 primary care patients. Alcohol Clin Exp Res, 2000. 24(5): p. 659–65.
    1. Pankow J, Simpson DD, Joe GW, Rowan-Szai GA, Knight K, Meason P. Examining Concurrent Validity and Predictive Utility for the Addiction Severity Index and Texas Christian University (TCU) Short Forms. J Offender Rehabil, 2012. 51(1–2): p. 78–95. 10.1080/10509674.2012.633021
    1. Prins A, Ouimette P, Kimerling R, Skeikh J. The primary care PTSD screen (PC-PTSD): development and operating characteristics. Primary Care Psychiatry, 2013. 9, 9–14.
    1. Radloff LS. The CES-D scale: A self report depression scale for research in the general population. Applied Psychological Measurements, 1977. 1, 385–401.
    1. Buscher A, Hartman C, Kallen MA, Giordano TP. Validity of self-report measures in assessing antiretroviral adherence of newly diagnosed, HAART-naive, HIV patients. HIV Clin Trials, 2011. 12(5): p. 244–54. 10.1310/hct1205-244
    1. Bradley H, Hall HI, Wolitski RJ, Van Handel MM, Stone AE, LaFlam M, et al. Vital Signs: HIV Diagnosis, Care, and Treatment Among Persons Living with HIV—United States, 2011. Morbidity and Mortality Weekly Report. 2014. 63(47);1113–1117.
    1. Bradley H, Mattson CL, Beer L, Huang P, Shouse RL, Medical Monitoring Project. Increased antiretroviral therapy prescription and HIV viral suppression among persons receiving clinical care for HIV infection. AIDS, 2016. 30(13):2117–24. 10.1097/QAD.0000000000001164
    1. Cohen SM, Hu X, Sweeney P, Johnson AS, Hall HI. HIV viral suppression among persons with varying levels of engagement in HIV medical care, 19 US jurisdictions. JAIDS, 2014. 67(5): 519–27. 10.1097/QAI.0000000000000349
    1. Castel AD, Tang W, Peterson J, Mikre M, Parenti D, Elion R, et al. Sorting through the lost and found: are patient perceptions of engagement in care consistent with standard continuum of care measures? J Acquir Immune Defic Syndr, 2015. 69 Suppl 1: p. S44–55.
    1. Vagenas P, Zelenev A, Altice FL, DiPaola A, Jordan AO, Teixeira PA, et al. HIV-infected men who have sex with men, before and after release from jail: the impact of age and race, results from a multi-site study. Aids Care-Psychological and Socio-Medical Aspects of Aids/Hiv, 2016. 28(1): p. 22–31.
    1. Williams CT, Kim S, Meyer J, Spaulding AC, Teixeira P, Avery A, et al. Gender differences in baseline health, needs at release, and predictors of care engagement among HIV-positive clients leaving jail. AIDS Behav, 2013. 17 Suppl 2: p. S195–202.
    1. Meyer JP, Cepeda J, Taxman FS, Altice FL. Sex-Related Disparities in Criminal Justice and HIV Treatment Outcomes: A Retrospective Cohort Study of HIV-Infected Inmates. Am J Public Health, 2015. 105(9): p. 1901–10. 10.2105/AJPH.2015.302687
    1. Mostashari F, Riley E, Selwyn PA, Altice FL. Acceptance and adherence with antiretroviral therapy among HIV-infected women in a correctional facility. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 1998. 18(4): p. 341–348.
    1. Starr SB. Estimating Gender Disparities in Federal Criminal Cases. American Law and Economics Review, 2015. 17(1): p. 127–159.
    1. Melendez RM, Exner TA, Ehrhardt AA, Dodge B, Remien RH, Rotheram-Borus MJ, et al. Health and health care among male-to-female transgender persons who are HIV positive. Am J Public Health, 2006. 96(6): p. 1034–7. 10.2105/AJPH.2004.042010
    1. Mizuno Y, Frazier EL, Huang P, Skarbinski J. Characteristics of Transgender Women Living with HIV Receiving Medical Care in the United States. LGBT Health, 2015. 2(3): p. 228–34. 10.1089/lgbt.2014.0099
    1. Nuttbrock L, Bockting W, Rosenblum A, Hwahng S, Mason M, Macri M, et al. Gender Abuse and Incident HIV/STI Among Transgender Women in New York City: Buffering Effect of Involvement in a Transgender Community. AIDS Behav, 2015. 19(8): p. 1446–53. 10.1007/s10461-014-0977-7
    1. Poteat T, Reisner SL, Radix A. HIV epidemics among transgender women. Curr Opin HIV AIDS, 2014. 9(2): p. 168–73. 10.1097/COH.0000000000000030
    1. Sevelius JM, Carrico A, Johnson MO. Antiretroviral therapy adherence among transgender women living with HIV. J Assoc Nurses AIDS Care, 2010. 21(3): p. 256–64. 10.1016/j.jana.2010.01.005
    1. Sevelius JM, Patouhas E, Keatley JG, Johnson MO. Barriers and facilitators to engagement and retention in care among transgender women living with human immunodeficiency virus. Ann Behav Med, 2014. 47(1): p. 5–16. 10.1007/s12160-013-9565-8
    1. Sevelius JM, Saberi P, Johnson MO. Correlates of antiretroviral adherence and viral load among transgender women living with HIV. AIDS Care, 2014. 26(8): p. 976–82. 10.1080/09540121.2014.896451

Source: PubMed

Sponsorzy i współpracownicy

Warunki medyczne

Interwencje lekowe

3
Subskrybuj